Resultados de la búsqueda 111-120 of 11712 for B cell lymphomas
... B-cell lymphoma 2 (BCL2) inhibitor. A Study to Evaluate Immune and Hematopoietic Cell Assessment in Clonal B Cell Conditions. Rochester, Minn. The purpose of ...
... cell lymphoma (DLBCL) patients with out of ... A Study to Evaluate Outpatient Blinatumomab in Subjects with Minimal Residual Disease (MRD) of B-precursor Acute ...
... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...
... B cell malignancies by engineering T cells to ... cell would result in T cell cytotoxic killing. ... lymphoma (DLBCL) patients with out of specification ...
A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis ... Although survivorship recommendations have been developed in areas such as lymphoma ...
Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ( ...
... Cell Lung Cancer. A Study of 177Lu-FAP-2286 in Advanced Solid Tumors ... B-cell lymphoma 2 (BCL2) inhibitor. Numeración de páginas Estudios clínicos.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?